Modulation of immune parameters in patients with metastatic renal-cell cancer receiving combination immunotherapy (IL-2, IFN alpha and autologous IL-2-activated lymphocytes).
about
Modulation of immune parameters in patients with metastatic renal-cell cancer receiving combination immunotherapy (IL-2, IFN alpha and autologous IL-2-activated lymphocytes).
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@ast
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@en
type
label
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@ast
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@en
prefLabel
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@ast
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@en
P2093
P2860
P1476
Modulation of immune parameter ...... s IL-2-activated lymphocytes).
@en
P2093
C H Lamers
J W Gratama
P I Schmitz
R L Bolhuis
P2860
P304
P356
10.1002/(SICI)1097-0215(19960117)65:2<152::AID-IJC5>3.0.CO;2-Y
P577
1996-01-01T00:00:00Z